Organogenesis Holdings (ORGO) Invested Capital (2015 - 2026)

Organogenesis Holdings' Invested Capital history runs 12 years deep, the most recent figure standing at $244.6 million for Q1 2026.

• In Q1 2026, Invested Capital rose 0.68% year-over-year to $244.6 million; the TTM figure through Mar 2026 stood at $244.6 million (up 0.68% YoY), while the FY2025 annual figure was $300.1 million, up 14.16% from the prior year.
• Invested Capital was $244.6 million for Q1 2026 at Organogenesis Holdings, down from $300.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $315.1 million in Q1 2022 to a low of $233.2 million in Q2 2025.
• Historically, Invested Capital has averaged $270.0 million across 5 years, with a median of $269.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital jumped 105.8% in 2022, then decreased 14.73% in 2023.
• A 5-year view of Invested Capital shows it stood at $270.2 million in 2022, then advanced by 5.16% to $284.1 million in 2023, then decreased by 7.48% to $262.9 million in 2024, then rose by 14.16% to $300.1 million in 2025, then fell by 18.52% to $244.6 million in 2026.
• The last three Invested Capital figures came in at $244.6 million (Q1 2026), $300.1 million (Q4 2025), and $255.1 million (Q3 2025), per Business Quant data.